0001019231-24-000023.txt : 20240514 0001019231-24-000023.hdr.sgml : 20240514 20240514175405 ACCESSION NUMBER: 0001019231-24-000023 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240501 FILED AS OF DATE: 20240514 DATE AS OF CHANGE: 20240514 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO CENTRAL INDEX KEY: 0001019231 ORGANIZATION NAME: STATE OF INCORPORATION: TX FISCAL YEAR END: 0831 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-38130 FILM NUMBER: 24946175 BUSINESS ADDRESS: STREET 1: 210 W. 7TH STREET, SUITE 1700 CITY: AUSTIN STATE: TX ZIP: 78701 BUSINESS PHONE: 5122251630 MAIL ADDRESS: STREET 1: 210 W. 7TH STREET, SUITE 1700 CITY: AUSTIN STATE: TX ZIP: 78701 FORMER NAME: FORMER CONFORMED NAME: UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO DATE OF NAME CHANGE: 20180508 FORMER NAME: FORMER CONFORMED NAME: UNIVERSITY OF TEXAS INVESTMENT MANAGMENT CO DATE OF NAME CHANGE: 19990330 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aileron Therapeutics, Inc. CENTRAL INDEX KEY: 0001420565 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 134196017 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12407 N. MOPAC EXPY. STREET 2: SUITE 250 #390 CITY: AUSTIN STATE: TX ZIP: 78758 BUSINESS PHONE: 7378021989 MAIL ADDRESS: STREET 1: 12407 N. MOPAC EXPY. STREET 2: SUITE 250 #390 CITY: AUSTIN STATE: TX ZIP: 78758 FORMER COMPANY: FORMER CONFORMED NAME: AILERON THERAPEUTICS INC DATE OF NAME CHANGE: 20071207 4/A 1 primary_doc.xml PRIMARY DOCUMENT X0508 4/A 2024-05-01 2024-05-01 0 0001420565 Aileron Therapeutics, Inc. ALRN 0001019231 UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 210 W. 7TH STREET, SUITE 1700 AUSTIN TX 78701 0 0 1 0 0 Common Stock 2024-05-01 4 S 0 3100 4.1 D 1807357 D Common Stock 2024-05-01 4 S 0 100 4.11 D 1807257 D Common Stock 2024-05-01 4 S 0 1750 4.12 D 1805507 D Common Stock 2024-05-01 4 S 0 380 4.13 D 1805127 D Common Stock 2024-05-01 4 S 0 1600 4.145 D 1803527 D Common Stock 2024-05-01 4 S 0 670 4.15 D 1802857 D Common Stock 2024-05-01 4 S 0 400 4.18 D 1802457 D Common Stock 2024-05-01 4 S 0 7923 4.25 D 1794534 D Common Stock 2024-05-01 4 S 0 310 4.26 D 1794224 D Common Stock 2024-05-01 4 S 0 317 4.265 D 1793907 D Common Stock 2024-05-01 4 S 0 100 4.27 D 1793807 D Common Stock 2024-05-01 4 S 0 200 4.275 D 1793607 D Common Stock 2024-05-01 4 S 0 337 4.28 D 1793270 D Common Stock 2024-05-01 4 S 0 200 4.285 D 1793070 D Common Stock 2024-05-01 4 S 0 2903 4.29 D 1790167 D Common Stock 2024-05-01 4 S 0 25 4.32 D 1790142 D Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the "Regents"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents. On May 1, 2024, the Reporting Person filed a Form 4 that, due to an administrative error, reported sales on April 29, 2024, and April 30, 2024, that were not executed. This amendment is being filed solely to remove such sales and correct the resulting amount of shares reported as beneficially owned by the Reporting Person following the transactions reported herein. /s/ Joan Moeller, Chief Operating Officer 2024-05-14